Table 2. The Relationships Between Clinical Characteristics and Each Inflammation-Based Score.

		GPS				NLR			SII
		GPS 0	GPS 1	GPS 2	P value	Low	High	P value	Low	High	P value
Age (years old)	< 65	68	31	7	0.063	98	8	0.222	62	44	0.276
	≥ 65	123	81	31		225	10		152	83
Gender	Male	83	65	25	0.007	158	15	0.003	93	80	0.001
	Female	108	47	13		165	3		121	47
Smoking	Never	109	40	9	<0.001	154	4	0.029	114	44	0.001
	Current/former	82	72	29		169	14		100	83
Histology	Adeno	163	81	24	0.002	258	10	0.024	182	86	< 0.001
	Others	28	31	14		65	8		32	41
pStage	I	150	91	24	0.081	256	9	0.008	178	87	< 0.001
	II - III	41	21	14		67	9		36	40
pT status	pT1	136	82	17	0.004	227	8	0.027	157	78	0.022
	pT2-3	55	30	21		96	10		57	49
pN status	pN0	163	100	29	0.162	281	11	0.008	192	100	0.006
	pN1-2	28	12	9		42	7		22	27
CEA	Normal	146	84	24	0.250	241	13	0.822	159	95	0.918
	High	45	28	14		82	5		55	32
CYFRA	Normal	166	91	26	0.026	272	11	0.023	181	102	0.314
	High	25	21	12		51	7		33	25

		PLR				PNI			ALI
		PLR 0	PLR 1	PLR 2	P value	PNI 0	PNI 1	P value	Low	High	P value
Age	< 65	62	40	4	0.084	82	24	0.001	37	69	0.941
	≥ 65	166	61	8		138	97		83	152
Gender	Male	106	58	9	0.040	109	64	0.554	73	100	0.006
	Female	122	43	3		111	57		47	121
Smoking	Never	114	41	3	0.086	105	53	0.486	43	115	0.004
	Current/former	114	60	9		115	68		77	106
Histology	Adeno	185	75	8	0.235	175	93	0.565	82	186	0.001
	Others	43	26	4		45	28		38	35
pStage	I	186	73	6	0.018	170	95	0.792	83	182	0.006
	II - III	42	28	6		50	26		37	39
pT status	pT1	162	68	5	0.111	157	78	0.190	76	159	0.103
	pT2-3	66	33	7		63	43		44	62
pN status	pN0	203	81	8	0.027	191	101	0.403	95	197	0.014
	pN1-2	25	20	4		29	20		25	24
CEA	Normal	171	74	9	0.946	169	85	0.186	87	167	0.537
	High	57	27	3		51	36		33	54
CYFRA	Normal	194	80	9	0.334	190	93	0.028	89	194	0.002
	High	34	21	3		30	28		31	27

GPS: Glasgow prognostic score; NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio; PNI: prognostic nutritional index; SII: systemic immune-inflammation index; ALI: advance lung cancer inflammation index; CEA: carcinoembryonic antigen; CYFRA21-1: cytokeratin 19 fragments.